Tag: Food & Drug Administration
FDA Approves New Treatment for Ulcerative Colitis
First oral medication approved for chronic use in moderate-to-severe active ulcerative colitis
FDA Approves Palynziq for Phenylketonuria
Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations
FDA Approves Aimovig to Prevent Migraines
Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo
FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures
Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure
FDA Approves Non-Opioid Treatment for Opioid Withdrawal
Lucemyra is an oral selective alpha 2-adrenergic receptor agonist
FDA Approves ‘Biosimilar’ Drug to Treat Certain Types of Anemia
Retacrit is biosimilar to the drugs Epogen and Procrit
FDA Expands Use of MS Drug to Include Children
Gilenya is the first multiple sclerosis drug approved for children
FDA Targets Clinics Offering Unapproved Stem Cell Therapies
Clinics claim unapproved therapies can treat number of diseases and conditions, including ALS and cancer
FDA Permits Marketing of New Device for Treating GI Bleeding
Hemospray is an aerosolized spray that delivers a mineral blend to the bleeding site
FDA Approves Drug Combo for Aggressive Thyroid Cancer
Dabrafenib + trametinib approved to treat BRAF-positive anaplastic thyroid cancer
